Omnia Wellness(OMWS)
$0.030.00 (0.00%)
OMWS
Omnia Wellness financials statements
$0.03
At close:0.00 (0.00%)
Omnia Wellness (OMWS) Ratios
2 Followers
Omnia Wellness Ratios
OMWS's free cash flow for Q2 2023 was $-52.89K. For the 2023 fiscal year, OMWS's free cash flow was increased by $3.00 and operating cash flow was $-52.89K. See a summary of the company’s cash flow.
| Ratios | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.04 | 0.06 | 0.01 | 0.07 | 0.84 |
| Quick Ratio | 0.04 | 0.06 | 0.01 | 0.07 | 0.84 |
| Cash Ratio | 0.00 | 0.01 | 0.00 | 0.07 | 0.84 |
| Solvency Ratio | -0.67 | -0.35 | -1.01 | -0.89 | -7.17 |
| Operating Cash Flow Ratio | -0.39 | -0.38 | -0.69 | -0.64 | -7.17 |
| Short-Term Operating Cash Flow Coverage | -0.52 | -0.43 | -1.23 | -0.85 | -7.17 |
| Net Current Asset Value | $ -7.33M | $ -5.32M | $ -32.82K | $ -14.25K | $ -618.00 |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 2.57 | 2.31 | 7.86 | 9.08 | 1.04 |
| Debt-to-Equity Ratio | -1.17 | -1.46 | -0.56 | -0.82 | -28.64 |
| Debt-to-Capital Ratio | 7.02 | 3.16 | -1.28 | -4.56 | 1.04 |
| Long-Term Debt-to-Capital Ratio | -0.51 | -0.60 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.45 | -0.63 | -0.07 | -0.09 | -27.64 |
| Debt Service Coverage Ratio | -0.35 | -0.31 | -1.80 | -1.15 | -6.97 |
| Interest Coverage Ratio | -1.26 | -2.65 | 0.00 | -11.83 | 0.00 |
| Debt to Market Cap | 0.13 | 0.16 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -2.52 | -3.67 | -0.55 | -0.78 | -0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | -170.81% | -189.40% | 3.74% | 97.72% | 0.00% |
| EBIT Margin | -974.39% | -741.77% | -15079.20% | -116.22% | 0.00% |
| EBITDA Margin | -827.66% | -617.14% | -14982.94% | -113.93% | 0.00% |
| Operating Profit Margin | -1168.00% | -741.77% | -15075.17% | -16.22% | 0.00% |
| Pretax Profit Margin | -1899.65% | -1021.17% | -15079.20% | -117.59% | 0.00% |
| Net Profit Margin | -1899.65% | -1021.17% | -15079.20% | -117.59% | 0.00% |
| Continuous Operations Profit Margin | -1899.65% | -1021.17% | -15079.20% | -117.59% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 162.64% | 137.67% | 100.03% | 725.04% | 102.82% |
| Return on Assets (ROA) | -233.83% | -103.40% | -1426.51% | -1096.14% | -750.38% |
| Return on Equity (ROE) | 106.20% | 65.57% | 102.02% | 99.05% | 20739.85% |
| Return on Capital Employed (ROCE) | 105.45% | 76.04% | 109.85% | 13.66% | 20170.68% |
| Return on Invested Capital (ROIC) | -337.24% | -102.65% | 270.96% | 75.98% | -729.79% |
| Return on Tangible Assets | -606.26% | -398.64% | -6603.92% | -1096.14% | -750.38% |
| Earnings Yield | -12.15% | -6.99% | -0.02% | -0.32% | -0.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.39 | 1.09 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.40 | 6.14 | 9.22 | 0.34 | 0.00 |
| Inventory Turnover | 32.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.43 | 0.70 | 0.00 | 54.98 | 0.00 |
| Asset Turnover | 0.12 | 0.10 | 0.09 | 9.32 | 0.00 |
| Working Capital Turnover Ratio | -0.06 | -0.11 | -0.01 | -1.59 | 0.00 |
| Cash Conversion Cycle | 13.79 | 276.63 | -39.57 | -1069.31 | 0.00 |
| Days of Sales Outstanding | 263.32 | 336.10 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 11.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 260.65 | 59.47 | 39.57 | 1069.31 | 0.00 |
| Operating Cycle | 274.45 | 336.10 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -8.05 | -0.74 | -378.14 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -8.05 | -0.74 | -378.14 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.36 | -0.32 | -1.23 | -0.85 | -7.17 |
| Operating Cash Flow to Sales Ratio | -7.45 | -7.38 | -102.03 | -0.83 | 0.00 |
| Free Cash Flow Yield | -5.36% | -11.90% | -0.01% | -0.23% | -0.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.23 | -14.30 | -4659.01 | -313.44 | -157.93 |
| Price-to-Sales (P/S) Ratio | 156.33 | 146.03 | 702540.85 | 368.57 | 0.00 |
| Price-to-Book (P/B) Ratio | -8.74 | -9.38 | -4753.14 | -310.47 | -32755.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -18.66 | -8.41 | -6885.57 | -442.82 | -159.50 |
| Price-to-Operating Cash Flow Ratio | -20.98 | -19.80 | -6885.57 | -442.82 | -159.50 |
| Price-to-Earnings Growth (PEG) Ratio | -0.08 | 0.00 | 46.59 | 6.32 | -0.10 |
| Enterprise Value Multiple | -21.41 | -27.33 | -4689.49 | -324.27 | -164.07 |
| Enterprise Value | 51.51M | 36.92M | 156.93M | 4.37M | 4.36M |
| EV to EBITDA | -21.41 | -27.33 | -4689.49 | -324.27 | -164.07 |
| EV to Sales | 177.19 | 168.69 | 702623.84 | 369.45 | 0.00 |
| EV to Free Cash Flow | -21.15 | -9.71 | -6886.39 | -443.88 | -159.52 |
| EV to Operating Cash Flow | -23.77 | -22.87 | -6886.39 | -443.88 | -159.52 |
| Tangible Book Value Per Share | -0.03 | -0.03 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.02 | -0.02 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.01 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.95 | 1.38 | 1.00 | 1.01 | 1.03 |
| Research & Development to Revenue | 3.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 7.58 | 4.75 | 150.79 | 1.03 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.39 | 0.72 | 0.68 | 0.71 | 0.99 |
Currency in USD
